This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Psychoactive substance index: Difference between revisions
Jump to navigation
Jump to search
>Kaylee No edit summary |
>Kenan Revise, refactor and cleanup source; make page responsive |
||
| Line 2: | Line 2: | ||
{{Submitsubstance}} | {{Submitsubstance}} | ||
{{Substances/Content}} | {{Substances/Content}} | ||
<noinclude>__NOTOC__</noinclude><onlyinclude> | <noinclude>__NOTOC__</noinclude> | ||
<onlyinclude> | |||
<div style='display: flex; flex-flow: row wrap;'> | |||
<div style='flex: 1; min-width: 200px;'> | |||
<div class="panel radius"> | <div class="panel radius" style="flex: 1; margin: 10px;"> | ||
<h3 class="panel-header">[[Psychedelics]] [[File:Eye.svg|x20px|right|link=]]</h3> | <h3 class="panel-header">[[Psychedelics]] [[File:Eye.svg|x20px|right|link=]]</h3> | ||
<ul class="featured-table"> | <ul class="featured-table"> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Lysergamide]]</h4> | <h4 class="media-heading">[[Lysergamide]]</h4> | ||
* [[1P-LSD]] | * [[1P-LSD]] | ||
| Line 19: | Line 19: | ||
* [[LSD]] | * [[LSD]] | ||
* [[LSZ]] | * [[LSZ]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Tryptamine]]s</h4> | <h4 class="media-heading">[[Tryptamine]]s</h4> | ||
* [[AMT]] | * [[AMT]] | ||
| Line 42: | Line 42: | ||
* [[DPT]] | * [[DPT]] | ||
* [[Ibogaine]] | * [[Ibogaine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Phenethylamine]]s</h4> | <h4 class="media-heading">[[Phenethylamine]]s</h4> | ||
* [[2C-B]] | * [[2C-B]] | ||
| Line 73: | Line 73: | ||
* [[MDMA]] | * [[MDMA]] | ||
* [[Bk-2C-B]] | * [[Bk-2C-B]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[beta-Carboline|β-Carbolines]]</h4> | <h4 class="media-heading">[[beta-Carboline|β-Carbolines]]</h4> | ||
* [[Harmaline]] | * [[Harmaline]] | ||
* [[Harmine]] | * [[Harmine]] | ||
* [[Tetrahydroharmine]] | * [[Tetrahydroharmine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">Others</h4> | <h4 class="media-heading">Others</h4> | ||
* [[5-MeO-DiBF]] | * [[5-MeO-DiBF]] | ||
| Line 89: | Line 89: | ||
* [[Myristicin]] | * [[Myristicin]] | ||
* [[Mirtazapine]] | * [[Mirtazapine]] | ||
</li> | </li> | ||
</ul> | </ul> | ||
</div> | </div> | ||
</div> | |||
<div class="panel radius"> | |||
<h3 class="panel-header">[[Entheogen]]s [[File:leaf.svg|x20px|right|link=]]</h3> | <div style='flex: 1; min-width: 200px;'> | ||
<ul class="featured-table"> | <div class="panel radius" style="flex: 1; margin: 10px;"> | ||
<li class="featured list-item"> | <h3 class="panel-header">[[Entheogen]]s [[File:leaf.svg|x20px|right|link=]]</h3> | ||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
* [[Ayahuasca]] | * [[Ayahuasca]] | ||
* [[Cannabis]] | * [[Cannabis]] | ||
| Line 112: | Line 114: | ||
* [[Salvinorin_A#Salvia_divinorum|Salvia divinorum]] | * [[Salvinorin_A#Salvia_divinorum|Salvia divinorum]] | ||
* [[Datura]] | * [[Datura]] | ||
</li> | </li> | ||
</ul> | |||
</div> | |||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<h3 class="panel-header">[[Dissociative]]s [[File:Chain-broken.svg|x20px|right|link=]]</h3> | |||
<ul class="featured-table"> | |||
<div class="panel radius"> | <li class="featured list-item"> | ||
<h3 class="panel-header">[[Dissociative]]s [[File:Chain-broken.svg|x20px|right|link=]]</h3> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">[[Arylcyclohexylamine|Arylcyclohexylamines]]</h4> | <h4 class="media-heading">[[Arylcyclohexylamine|Arylcyclohexylamines]]</h4> | ||
* [[2-Fluorodeschloroketamine]] | * [[2-Fluorodeschloroketamine]] | ||
| Line 133: | Line 134: | ||
* [[Phencyclidine]] (''PCP'') | * [[Phencyclidine]] (''PCP'') | ||
* [[Trifluoroketamine]] | * [[Trifluoroketamine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Morphinan]]s</h4> | <h4 class="media-heading">[[Morphinan]]s</h4> | ||
* [[Dextromethorphan]] (''DXM'') | * [[Dextromethorphan]] (''DXM'') | ||
* [[Dextrorphan]] (''DXO'') | * [[Dextrorphan]] (''DXO'') | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Piperidine]]s</h4> | <h4 class="media-heading">[[Piperidine]]s</h4> | ||
* [[Diphenidine]] | * [[Diphenidine]] | ||
* [[Methoxphenidine]] (''MXP'') | * [[Methoxphenidine]] (''MXP'') | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">Others</h4> | <h4 class="media-heading">Others</h4> | ||
* [[Ephenidine]] | * [[Ephenidine]] | ||
| Line 153: | Line 154: | ||
* [[Myristicin]] | * [[Myristicin]] | ||
* [[Nitrous oxide]] | * [[Nitrous oxide]] | ||
</li> | </li> | ||
</ul> | |||
</div> | |||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<h3 class="panel-header">[[Deliriant]]s [[File:Spider.svg|x20px|right|link=]]</h3> | |||
<div class="panel radius"> | <ul class="featured-table"> | ||
<h3 class="panel-header">[[Deliriant]]s [[File:Spider.svg|x20px|right|link=]]</h3> | <li class="featured list-item"> | ||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">[[Tropane alkaloid]]s</h4> | <h4 class="media-heading">[[Tropane alkaloid]]s</h4> | ||
* [[Datura#Chemistry|Atropine]] | * [[Datura#Chemistry|Atropine]] | ||
* [[Datura#Chemistry|Hyoscyamine]] | * [[Datura#Chemistry|Hyoscyamine]] | ||
* [[Datura#Chemistry|Scopolamine]] | * [[Datura#Chemistry|Scopolamine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Antihistamine]]s</h4> | <h4 class="media-heading">[[Antihistamine]]s</h4> | ||
* [[Diphenhydramine]] | * [[Diphenhydramine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">Others</h4> | <h4 class="media-heading">Others</h4> | ||
* [[Mirtazapine]] | * [[Mirtazapine]] | ||
* [[Benzydamine]] | * [[Benzydamine]] | ||
</li> | </li> | ||
</ul> | |||
</ul> | </div> | ||
</div> | </div> | ||
<div | |||
<li class="featured list-item"> | <div style='flex: 1; min-width: 200px;'> | ||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<h3 class="panel-header">[[Cannabinoid]]s [[File:Cannabis leaf (1).svg|25px|right|link=]]</h3> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">[[Cannabinoid#Phytocannabinoids|Phytocannabinoid]]s</h4> | <h4 class="media-heading">[[Cannabinoid#Phytocannabinoids|Phytocannabinoid]]s</h4> | ||
* [[Cannabis#Chemistry|Cannabidiol]] (''CBD'') | * [[Cannabis#Chemistry|Cannabidiol]] (''CBD'') | ||
* [[Cannabis#Chemistry|Cannabinol]] (''CBN'') | * [[Cannabis#Chemistry|Cannabinol]] (''CBN'') | ||
* [[Cannabis#Chemistry|Tetrahydrocannabinol]] (''THC'') | * [[Cannabis#Chemistry|Tetrahydrocannabinol]] (''THC'') | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Synthetic cannabinoid|Synthetic cannabinoid]]s</h4> | <h4 class="media-heading">[[Synthetic cannabinoid|Synthetic cannabinoid]]s</h4> | ||
* [[5F-AKB-48]] | * [[5F-AKB-48]] | ||
| Line 203: | Line 204: | ||
* [[THJ-2201]] | * [[THJ-2201]] | ||
* [[STS-135]] | * [[STS-135]] | ||
</li> | </li> | ||
</ul> | |||
</ul> | </div> | ||
</div> | |||
<div class="panel radius"> | <div class="panel radius" style="flex: 1; margin: 10px;"> | ||
<h3 class="panel-header">Miscellaneous [[File:Cogs.svg|x20px|right|link=]]</h3> | <h3 class="panel-header">Miscellaneous [[File:Cogs.svg|x20px|right|link=]]</h3> | ||
<ul class="featured-table"> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[GABAA receptor|GABA-A receptor agonists]]</h4> | <h4 class="media-heading">[[GABAA receptor|GABA-A receptor agonists]]</h4> | ||
* [[Ibotenic acid]] | * [[Ibotenic acid]] | ||
* [[Muscimol]] | * [[Muscimol]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[k-opioid receptor|κ-opioid receptor agonists]]</h4> | <h4 class="media-heading">[[k-opioid receptor|κ-opioid receptor agonists]]</h4> | ||
* [[Ibogaine]] | * [[Ibogaine]] | ||
* [[Salvinorin A]] | * [[Salvinorin A]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Sigma receptors|Sigmaergics]]</h4> | <h4 class="media-heading">[[Sigma receptors|Sigmaergics]]</h4> | ||
* [[DXM]] | * [[DXM]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">Combinations</h4> | <h4 class="media-heading">Combinations</h4> | ||
* [[Ayahuasca]] | * [[Ayahuasca]] | ||
* [[DXM & DPH in combination|DXM & DPH]] | * [[DXM & DPH in combination|DXM & DPH]] | ||
</li> | </li> | ||
</ul> | |||
</ | </div> | ||
</div> | |||
</div> | </div> | ||
<li class="featured list-item"> | <div style='display: flex; flex-flow: row wrap;'> | ||
<div style='flex: 1; min-width: 200px;'> | |||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<h3 class="panel-header">[[Depressant]]s [[File:arrow-down.svg|x20px|right|link=]]</h3> | |||
<ul class="featured-table"> | |||
<li class="featured list-item"> | |||
<h4 class="media-heading">[[Benzodiazepine|Benzodiazepines]]</h4> | <h4 class="media-heading">[[Benzodiazepine|Benzodiazepines]]</h4> | ||
* [[Alprazolam]] (''Xanax'') | * [[Alprazolam]] (''Xanax'') | ||
| Line 259: | Line 259: | ||
* [[Pyrazolam]] | * [[Pyrazolam]] | ||
* [[Temazepam]] | * [[Temazepam]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Substituted thienodiazepine|Thienodiazepines]]</h4> | <h4 class="media-heading">[[Substituted thienodiazepine|Thienodiazepines]]</h4> | ||
* [[Deschloroetizolam]] | * [[Deschloroetizolam]] | ||
* [[Etizolam]] | * [[Etizolam]] | ||
* [[Metizolam]] | * [[Metizolam]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Opioids]]</h4> | <h4 class="media-heading">[[Opioids]]</h4> | ||
* [[Acetylfentanyl]] | * [[Acetylfentanyl]] | ||
| Line 284: | Line 284: | ||
* [[Tramadol]] | * [[Tramadol]] | ||
* [[U-47700]] | * [[U-47700]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[GABA|GABAergics]]</h4> | <h4 class="media-heading">[[GABA|GABAergics]]</h4> | ||
* [[Alcohol]] | * [[Alcohol]] | ||
| Line 297: | Line 297: | ||
* [[Methaqualone]] | * [[Methaqualone]] | ||
* [[Phenibut]] | * [[Phenibut]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Antipsychotic]]s</h4> | <h4 class="media-heading">[[Antipsychotic]]s</h4> | ||
* [[Quetiapine]] | * [[Quetiapine]] | ||
* [[Prochlorperazine]] | * [[Prochlorperazine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">Others</h4> | <h4 class="media-heading">Others</h4> | ||
* [[Pregabalin]] | * [[Pregabalin]] | ||
* [[Gabapentin]] | * [[Gabapentin]] | ||
* [[Zopiclone]] | * [[Zopiclone]] | ||
</li> | </li> | ||
</ul> | </ul> | ||
</div> | |||
</div> | |||
< | <div style='flex: 1; min-width: 200px;'> | ||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<div class="panel radius"> | <h3 class="panel-header">[[Stimulants]] [[File:arrow-up.svg|x20px|right|link=]]</h3> | ||
<h3 class="panel-header">[[Stimulants]] [[File:arrow-up.svg|x20px|right|link=]]</h3> | |||
<ul class="featured-table"> | <ul class="featured-table"> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Substituted amphetamine|Amphetamines]]</h4> | <h4 class="media-heading">[[Substituted amphetamine|Amphetamines]]</h4> | ||
* [[Amphetamine]] | * [[Amphetamine]] | ||
| Line 326: | Line 328: | ||
* [[2-Aminoindane|2-AI]] | * [[2-Aminoindane|2-AI]] | ||
* [[NM-2-AI]] | * [[NM-2-AI]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Phenidates]]</h4> | <h4 class="media-heading">[[Phenidates]]</h4> | ||
*[[4F-EPH]] | *[[4F-EPH]] | ||
| Line 335: | Line 337: | ||
*[[Isopropylphenidate]] | *[[Isopropylphenidate]] | ||
*[[Methylphenidate]] | *[[Methylphenidate]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Substituted cathinone|Cathinones]]</h4> | <h4 class="media-heading">[[Substituted cathinone|Cathinones]]</h4> | ||
* [[Butylone]] (''βk-MDBD'') | * [[Butylone]] (''βk-MDBD'') | ||
| Line 347: | Line 349: | ||
* [[Mexedrone]] | * [[Mexedrone]] | ||
* [[A-PVP]] | * [[A-PVP]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">[[Substituted xanthine|Xanthines]]</h4> | <h4 class="media-heading">[[Substituted xanthine|Xanthines]]</h4> | ||
* [[Caffeine]] | * [[Caffeine]] | ||
</li> | </li> | ||
<li class="featured list-item"> | <li class="featured list-item"> | ||
<h4 class="media-heading">Others</h4> | <h4 class="media-heading">Others</h4> | ||
* [[3-FPM]] | * [[3-FPM]] | ||
| Line 362: | Line 364: | ||
* [[Poppers]] | * [[Poppers]] | ||
* [[Bromantane]] | * [[Bromantane]] | ||
</li> | </li> | ||
</ul> | |||
</div> | |||
</div> | |||
< | <div style='flex: 1; min-width: 200px;'> | ||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<h3 class="panel-header">[[Nootropics]] [[File:graduation-cap.svg|x20px|right|link=]]</h3> | |||
<div class="panel radius"> | |||
<h3 class="panel-header">[[Nootropics]] [[File:graduation-cap.svg|x20px|right|link=]]</h3> | <ul class="featured-table"> | ||
<ul class="featured-table"> | <li class="featured list-item"> | ||
<li class="featured list-item"> | |||
* [[Aniracetam]] | * [[Aniracetam]] | ||
* [[Armodafinil]] | * [[Armodafinil]] | ||
| Line 384: | Line 387: | ||
* [[Tianeptine]] | * [[Tianeptine]] | ||
* [[Tyrosine]] | * [[Tyrosine]] | ||
</li> | </li> | ||
</ul> | </ul> | ||
</div> | |||
<div class="panel radius" style="flex: 1; margin: 10px;"> | |||
<div class="panel radius"> | <h3 class="panel-header">[[Entactogens]] [[File:heart.svg|x20px|right|link=]]</h3> | ||
<h3 class="panel-header">[[Entactogens]] [[File:heart.svg|x20px|right|link=]]</h3 | |||
<li class="featured list-item"> | <ul class="featured-table"> | ||
<li class="featured list-item"> | |||
* [[MDMA]] | * [[MDMA]] | ||
* [[MDAI]] | * [[MDAI]] | ||
| Line 398: | Line 401: | ||
* [[5-APB]] | * [[5-APB]] | ||
* [[6-APB]] | * [[6-APB]] | ||
</li> | </li> | ||
</ul> | |||
</ | </div> | ||
</div> | |||
</div> | </div> | ||
</onlyinclude> | </onlyinclude> | ||
{{Effects/SeeAlso}} | {{Effects/SeeAlso}} | ||
Revision as of 11:10, 19 May 2016
Template:Submitsubstance A psychoactive substance is a chemical substance—other than a nutrient or essential dietary ingredient—that alters brain function to produce temporary changes in sensation, perception, mood, consciousness, cognition, and behavior.
Psychoactive substances have been used by humans for a variety of purposes since recorded history. For example, they may be used as medicine, as recreational substances for their euphoric effects and novelty value, as entheogens for ritual or spiritual purposes, or as scientific research probes for studying the brain and mind. The latter two have particular relevance for practitioners of psychonautics.
The Psychoactive Substance Index (PSI) is designed to catalog and provide relevant, accurate, and unbiased information for any and all mind-altering substances known to humankind, with a special focus on those with potential applications as mind-expanding tools.
The individual articles detail not just the history, chemistry, pharmacology, toxicity, and legality of each substance, but also its user-reported subjective effects (i.e. phenomenology). This is achieved in accordance with a standardized system of definitions and terminologies proposed in the Subjective Effect Index (SEI).
Please see our summary index to view conveniently condensed versions of each article.
Note: This list should only include substances that have a documented history of human use. Do not include substances that are merely theoretical or lack reliable user experience reports and data!
Psychedelics 
-
Lysergamide
-
Tryptamines
- AMT
- 4-AcO-DiPT
- 4-AcO-DMT (Psilacetin)
- 4-AcO-MET
- 4-HO-DET (Ethocin)
- 4-HO-MET (Metocin)
- Psilocin (4-HO-DMT)
- 4-HO-MiPT
- Psilocybin (4-PO-DMT)
- Bufotenin (5-HO-DMT)
- 5-MeO-DiBF
- 5-MeO-DMT
- 5-MeO-DALT
- 5-MeO-DiPT
- 5-MeO-MiPT
- DiPT
- DMT
- DPT
- Ibogaine
-
Phenethylamines
-
β-Carbolines
-
Others
Dissociatives 
-
Arylcyclohexylamines
-
Morphinans
- Dextromethorphan (DXM)
- Dextrorphan (DXO)
-
Piperidines
- Diphenidine
- Methoxphenidine (MXP)
-
Others
Miscellaneous 
Stimulants 
-
Amphetamines
-
Phenidates
-
Cathinones
- Butylone (βk-MDBD)
- Ethyl-Hexedrone
- Methylone (βk-MDMA)
- 4-MEC
- 3-MMC
- Mephedrone (4-MMC)
- Mexedrone
- A-PVP
-
Xanthines
-
Others
